Peptide AOD 9604 (5mg)

Fragment peptide analog — designed for controlled metabolic and lipolytic research studies.

• AOD-9604 is a synthetic peptide fragment (176–191) of the human growth hormone sequence.
• Studied in pre-clinical and in vitro models for its potential activity on lipid metabolism and fatty acid oxidation pathways.
• Every batch tested by Vanguard Laboratory for peptide identity, purity, and sequence accuracy.

AOD-9604 is a 15-amino-acid peptide fragment derived from the C-terminal region of growth hormone. It has been shown in experimental settings to regulate lipolysis and inhibit lipogenesis through specific receptor-mediated pathways

Research indicates potential effects on beta-oxidation and energy metabolism without influencing insulin sensitivity or blood glucose levels in animal studies

Laboratory trials have also explored AOD-9604 as a non-lipogenic analog for evaluating growth hormone–related metabolic pathways

Regulatory Status: AOD-9604 is not FDA-approved for human or veterinary use. This product is supplied strictly for laboratory research applications.